¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"cellular immune theory"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • immune reaction
    ¸é¿ª¹ÝÀÀ
  • immune reactivity
    ¸é¿ª¹ÝÀÀ¼º
  • immune response
    ¸é¿ª¹ÝÀÀ
  • immune response gene
    ¸é¿ª¹ÝÀÀÀ¯ÀüÀÚ
  • immune selection
    ¸é¿ª¼±ÅÃ
  • immune serum
    ¸é¿ªÇ÷û
  • immune surveillance
    ¸é¿ª°¨½Ã
  • immune system
    ¸é¿ªÃ¼°è
  • immune thrombocytopenia
    ¸é¿ª¼ºÇ÷¼ÒÆÇ°¨¼Ò(Áõ)
  • immune thrombocytopenic purpura
    ¸é¿ª¼ºÀúÇ÷¼ÒÆÇÀÚ(»ö)¹Ý
  • immune-complex disease
    ¸é¿ªº¹ÇÕüº´
  • immune-mediated hemolysis
    ¸é¿ª¸Å°³¿ëÇ÷
  • memory immune response
    ¸é¿ª±â¾ï¹ÝÀÀ
  • primary immune response
    ÀÏÂ÷¸é¿ª¹ÝÀÀ
  • secondary immune response
    ÀÌÂ÷¸é¿ª¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • spontaneous generation theory
    ÀÚ¿¬¹ß»ý¼³
  • supersaturation/crystallization theory
    °úÆ÷È­°áÁ¤È­¼³
  • theory
    Çм³, ¼³, ÀÌ·Ð
  • template theory
    Ç×ü»ý»êÁö½Ã¼³, Ç×ü»ý»êÃø¼â¼³
  • acquired immune deficiency
    ÈÄõ¸é¿ª°áÇÌ
  • acquired immune deficiency syndrome
    ÈÄõ¸é¿ª°áÇÌÁõÈıº, ¿¡ÀÌÁî
  • ancillary immune system
    º¸Á¶¸é¿ª°è
  • immune adherence
    ¸é¿ªºÎÂø
  • immune bacteriolysis
    ¸é¿ª¼¼±Õ¿ëÇØ
  • circulating immune complex
    Ç÷Á߸鿪º¹ÇÕü
  • drug-induced immune complex
    ¾àÁ¦À¯¹ß¸é¿ªº¹ÇÕü
  • immune complex
    ¸é¿ªº¹ÇÕü
  • immune conglutinin
    ¸é¿ª±³Âø¼Ò
  • immune cytolysis
    ¸é¿ª¼¼Æ÷¿ëÇØ
  • immune deficiency
    (¢¡immunodeficiency) ¸é¿ª°áÇÌ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • immune deposit disease
    ¸é¿ª(±Û·ÎºÒ¸°)Ä§ÂøÁõÈıº.
  • immune deposit disease
    ¸é¿ª(±Û·ÎºÒ¸°)Ä§ÂøÁõÈıº.
  • immune deviation
    ¸é¿ªÆíÀ§(Øóæ¹ø¶êÈ).
  • immune disorder
    ¸é¿ª Àå¾Ö
  • immune disorders
    ¸é¿ªÀå¾Ö(Øóæ¹î¡äô)
  • immune electron microscopy
    ¸é¿ªÀüÀÚÇö¹Ì°æ¹ý.
  • immune electrophoresis
    ¸é¿ªÀü±â¿µµ¿¹ý.
  • immune elimination
    ¸é¿ªÀ̹°Á¦°Å.
  • immune enhancement
    ¸é¿ªÇÐÀûÃËÁø (Á¾¾çÁõ½ÄÀÇ)
  • immune globulin
    ¸é¿ª±Û·ÎºÒ¸°.
  • immune hemolysis
    ¸é¿ª¿ëÇ÷(¹ÝÀÀ).
  • immune hemolytic anemia
    ¸é¿ª¿ëÇ÷¼º ºóÇ÷
  • immune incompatibility (hemolytic anemia)
    ¸é¿ªºÎÀûÇÕ(¿ëÇ÷¼ººóÇ÷)
  • immune interferon (Interferon-¥ã)
    ¸é¿ªÀÎÅÍÆä·Ð (°¨¸¶ÀÎÅÍÆä·Ð)
  • immune memory
    ¸é¿ªÀû ±â¾ï(¡­ÑÀåã).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • enhancement, immune
    ¸é¿ªÁõ°­Çö»ó
  • globulin, immune
    ¸é¿ª±Û·ÎºÒ¸°
  • globulin, immune serum
    ¸é¿ªÇ÷û±Û·ÎºÒ¸°
  • hemagglutination, immune adherence
    ¸é¿ªºÎÂø Ç÷±¸ÀÀÁý
  • hemolysis, immune
    ¸é¿ª¿ëÇ÷
  • human rabies immune globulin
  • human serum immune globulin
    Àΰ£Ç÷û¸é¿ª±Û·ÎºÒ¸°.
  • human serum immune globulin
    Àΰ£Ç÷û¸é¿ª±Û·ÎºÒ¸°.
  • human serum immune globulin
    Àΰ£Ç÷û¸é¿ª±Û·ÎºÒ¸°.
  • immune
    ¸é¿ª(¼º)(Øóæ¹àõ)ÀÇ.
  • immune adherence
    ¸é¿ªºÎÂø(Øóæ¹Üõó·).
  • immune adherence hemagglutination
    ¸é¿ªºÎÂø Ç÷±¸ÀÀÁý
  • immune adherence reaction
    ¸é¿ªºÎÂø¹ÝÀÀ.
  • immune amboceptor =i. body
    ¾ç¼öü(å»áôô÷).
  • immune amnesia syndrome
    ¸é¿ª ±â¾ï»ó½Ç ÁõÈıº
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • mechanistic theory
    ±â°èÀûÀÌ·Ð(ѦÌþîÜ×âÖå)
  • membron theory
    ¸Éºê·ÐÀÌ·Ð(ìµÖå)
  • molecular orbital theory
    ºÐÀڱ˵µ¼³(ÝÂí­ÏùÔ³àã)
  • Morawitz theory
    ¸ð¶óºñÃ÷¼³(àã)
  • mosaic theory
    ¸ðÀÚÀÌÅ©¼³(àã)
  • multistep induction theory
    ´Ù´Ü°è À¯µµ·Ð(ÒýÓ«Í­ë¯ÓôÖå)
  • mutation theory
    º¯ÀÌ·Ð(ܨì¶Öå)
  • neutral theory of molecular evolution
    Á߸³ºÐÀÚÁøÈ­·Ð(ñ騡ÝÂí­òäûùÖå)
  • oncogene theory
    ¾ÏÀ¯ÀüÀÚÀÌ·Ð(äßë¶îîí­ìµÖå)
  • one-hit theory
    Àϰݼ³(àã)
  • plate theory
    ÆòÆÇÀÌ·Ð(øÁ÷ù×âÖå)
  • polyaffinity theory
    ´Ùģȭ¼º ÀÌ·Ð(ÒýöÑûúàõ×âÖå)
  • polyetiological theory
    ´ÙÀÎ ÀÌ·Ð(Òýì××âÖå)
  • prothrombin derivatives theory
    ÇÁ·ÎÆ®·Òºó À¯µµÃ¼ ÀÌ·Ð(ë¯Óôô÷×âÖå)
  • quantum theory
    ¾çÀÚ·Ð(åÕí­Öå)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
LDCC lectin-dependent cellular cytotoxicity
MICC mitogen-induced cellular cytotoxicity
RBPC cellular retinol-binding protein
TCRP total cellular receptor pool
AIDS Acquired Immuno(Immune)-Deficiency Syndrome; ÈÄõ¼º ¸é¿ª °áÇÌ ÁõÈıº
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
CRALBP Cellular retinaldehyde binding protein
CRABP Cellular retinoic acid binding protein
CRABP-I Cellular retinoic acid binding protein I
CRABP II Cellular retinoic acid binding protein II
CRBP II Cellular retinol binding protein II
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Jackson's theory
    Àè½¼ ¼³
    ÀηùÀÇ ³ú¼ö´Â °¡Àå »óºÎ¿¡ ÀÖÀ»¼ö·Ï ÁøÈ­ÇÑ °ÍÀÌ´Ù.
  • Kubelka-Munk theory
    Äíº§Å°-¸ÛÅ©¼³
  • libido theory
    ¸®ºñµµ Çм³, ¼º¿å¼³
    S. ÇÁ·ÎÀÌÆ®´Â ¸®ºñµµ°¡ »çÃá±â¿¡ °©Àڱ⠳ªÅ¸³ª´Â °ÍÀÌ ¾Æ´Ï¶ó ž¸é¼­ºÎÅÍ ¼­¼­È÷ ¹ß´ÞÇÏ´Â °ÍÀ̶ó°í »ý°¢ÇÏ¿´´Ù. Áï ¼º º»´ÉÀº ±¸¼ø±â, Ç×¹®±â¸¦ ÅëÇØ ¹ß´ÞÇÏ´Ù°¡ 5¼¼°æ ÀýÁ¤¿¡ À̸¥ ÈÄ, ¾ï¾ÐÀ» ¹Þ¾Æ ÀáÀç±â¿¡ À̸£°í, »çÃá±â¿¡ ´Ù½Ã ¼º¿åÀ¸·Î ³ªÅ¸³­´Ù°í ÇÑ´Ù. ±×·¯³ª ¸®ºñµµ´Â, Áßµµ¿¡¼­ ¹ß´ÞÀÌ ÁßÁöµÇ±âµµ Çϰí, ¿ÏÀüÈ÷ ¹ß´ÞÇß´Ù°¡ °Å²Ù·Î µÇµ¹¾Æ°¡´Â °æ¿ìµµ ÀÖ´Ù. ÀÌ»ó ¼º¿å
  • menophylectic theory
    ÀÏ¿ø¼³
  • MIE theory
    MIE ¼³
  • migration theory
    À̵¿¼³
  • monoclonal theory
    ´ÜÀÏ ¼¼Æ÷ À¯·¡¼³
  • oxidation theory
    »êÈ­¼³
  • polychromatic theory
    ´Ù»ö¼³
  • Prothero cone theory
    ÇÁ·Îµ¥·Î ÄÜ ¼³
  • psychological theory
    ½É¸®ÇÐ ÀÌ·Ð
  • psychosexual stage theory
    ½É¸® ¼ºÀû ´Ü°è ÀÌ·Ð
  • receptor theory
    ¼ö¿ë±â ÀÌ·Ð
    Ç×ü »ý¼º ¼¼Æ÷ÀÇ Ç¥¸é¿¡´Â ƯÁ¤ Ç×ü¿¡ »óÀÀÇÏ´Â Ç׿øÀÌ °áÇÕÇ϶ó ¼ö¿ëü°¡ Á¸ÀçÇÏ¸ç ±× ¼ö¿ëüÀÇ ±¸Á¶´Â Ç×üÀÇ ±¸Á¶¿Í °°´Ù´Â ÀÌ·Ð.
  • selection theory
    ¼±Åü³
  • symbiosis theory
    °ø»ý¼³
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
immune precipitation <immunology> The precipitation of a multivalent antigen by a bivalent antibody, resulting in the formation of a large complex. The antibody and antigen must be soluble. Precipitation usually occurs when there is near equivalence between antibody and antigen concentrations.
(18 Nov 1997)
immune protein An immunoglobulin molecule that has a specific amino acid sequence by virtue of which it interacts only with the antigen that induced its synthesis in cells of the lymphoid series (especially plasma cells) or with antigen closely related to it. Antibodies are classified according to their ode of action as agglutinins, bacteriolysins, haemolysins, opsonins, precipitins, etc.
(18 Nov 1997)
immune reaction Antigen-antibody reaction indicating a certain degree of resistance, usually in reference to the 36-to 48-hour reaction in vaccination against smallpox; because the degree of resistance indicated by the reaction is not true immunity and may disappear relatively rapidly there is a tendency to refer to the immune reaction as an allergic reaction.
(05 Mar 2000)
immune response <immunology> Alteration in the reactivity of an organisms immune system in response to an antigen, in vertebrates, this may involve antibody production, induction of cell-mediated immunity, complement activation or development of immunological tolerance.
(18 Nov 1997)
immune-response gene <molecular biology> Any of several genes of the major histocompatibility complex that control the immune response of lymphocytes to specific antigens.
(09 Oct 1997)
immune response genes Gene's in the HLA-D region of the histocompatibility complex of human chromosome 6 which control the immune response to specific antigens.
(05 Mar 2000)
immune sera Serum that contains antibodies. It is obtained from an animal that has been immunised either by antigen injection or infection with microorganisms containing the antigen.
(12 Dec 1998)
immune serum Blood serum containing antibodies.
(14 Nov 1997)
immune serum globulin A sterile solution of globulin's that contains many antibodies normally present in adult human blood; a passive immunizing agent frequently used for prophylaxis against hepatitis A.
(05 Mar 2000)
immune suppression Suppression of the immune response by some compound or agent.
(05 Mar 2000)
immune surveillance <immunology> The hypothesis that lymphocyte traffic ensures that all or nearly all parts of the vertebrate body are surveyed by visiting lymphocytes in order to detect any altered self material, for example mutant cells.
(18 Nov 1997)
immune system <immunology> The body system, made up of many organs and cells, that defends the body against infection, disease and foreign substances. The immune system is often stimulated in specific ways to fight cancer cells.
(16 Dec 1997)
immune thrombocytopenia Thrombocytopenia associated with antiplatelet antibodies.
See: isoimmune neonatal thrombocytopenia, autoimmune neonatal thrombocytopenia.
(05 Mar 2000)
immune thrombocytopenic purpura <haematology> A low number of platelets in the blood, which is common in people with HIV, but often resolves as immune deficiency worsens. HIV-related ITP usually does not have serious consequences. Its cause has not been definitely determined. Treatment with AZT frequently alleviates the condition.
(09 Oct 1997)
immune tolerance The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (foetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á